Climb Bio, Inc.
CLYM
$2.33
-$0.15-6.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.10M | 5.69M | 4.95M | 4.88M | 3.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.68M | 23.02M | 10.91M | 8.39M | 4.71M |
| Operating Income | -10.68M | -23.02M | -10.91M | -8.39M | -4.71M |
| Income Before Tax | -8.67M | -20.78M | -8.42M | -8.90M | -54.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.67M | -20.78M | -8.42M | -8.90M | -54.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.67M | -20.78M | -8.42M | -8.90M | -54.89M |
| EBIT | -10.68M | -23.02M | -10.91M | -8.39M | -4.71M |
| EBITDA | -10.66M | -- | -- | -- | -- |
| EPS Basic | -0.13 | -0.31 | -0.13 | -0.13 | -1.81 |
| Normalized Basic EPS | -0.08 | -0.20 | -0.09 | -0.05 | -0.07 |
| EPS Diluted | -0.13 | -0.31 | -0.13 | -0.13 | -1.81 |
| Normalized Diluted EPS | -0.08 | -0.20 | -0.09 | -0.05 | -0.07 |
| Average Basic Shares Outstanding | 67.59M | 67.46M | 64.74M | 67.01M | 30.35M |
| Average Diluted Shares Outstanding | 67.59M | 67.46M | 64.74M | 67.01M | 30.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |